Bill Summary

HB 1617 Stem Cell Therapy (2025 Session)
Stem Cell Therapy: Authorizes licensed health care providers to perform stem cell therapy; specifies requirements for stem cells that may be used by such providers; requires such providers to adhere to applicable current good manufacturing practices in performance of such therapies; requires health care providers to provide specified written notice to patients before performing any stem cell therapy; specifies requirements for written notice; provides advertisement requirements; requires health care providers to obtain written consent from patient or his or her representative before performing therapy; specifies requirements for consent form; provides applicability; provides for disciplinary action; requires DOH to adopt rules. Effective Date: July 1, 2025
02/28/25
HOUSE 
Filed
03/05/25
HOUSE 
Referred to Health Professions & Programs Subcommittee; Health & Human Services Committee
03/05/25
HOUSE 
Now in Health Professions & Programs Subcommittee
1617
Filed on 02/28/25
PDF
No amendments to this bill text filed.
Research & Reports
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.

No reports related to this bill.

Upcoming Events
Florida's most comprehensive legislative calendar. Learn more.

No events are scheduled at this time.

Press Releases
Related Press Announcements. Learn more.

No press releases related to this bill.

Features above are available to LobbyTools subscribers. Request a free demo or call (850) 915-0100 ext. 2 to learn more.